Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Dermatofibrosarcoma × Nivolumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 71 Carcinoma, Renal Cell 41 Neoplasm Metastasis 30 Neoplasms 29 Squamous Cell Carcinoma of Head and Neck 25 Lung Neoplasms 24 Colorectal Neoplasms 22 Carcinoma, Hepatocellular 19 Hodgkin Disease 17 Small Cell Lung Carcinoma 16 Carcinoma, Transitional Cell 12 Urinary Bladder Neoplasms 11 Prostatic Neoplasms 11 Multiple Myeloma 11 Advanced Cancer 11 Pancreatic Neoplasms 10 Ovarian Neoplasms 10 Lymphoma 10 Head and Neck Neoplasms 10 Glioblastoma 10 Triple Negative Breast Neoplasms 9 Kidney Neoplasms 9 Breast Neoplasms 9 Recurrence 8 Leukemia, Myeloid, Acute 8 Glioma 8 Stomach Neoplasms 7 Myelodysplastic Syndromes 7 Lymphoma, Non-Hodgkin 7

Interventions

Doxorubicin 4 pazopanib 2 Ifosfamide 2 saracatinib 1 sapanisertib 1 indolepropanol phosphate 1 Watchful Waiting 1 TTI-621 1 Sunitinib 1 Razoxane 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiation 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 MLN 8237 1 Imatinib Mesylate 1 HhAntag691 1 Gene Expression Profiling 1 Dexrazoxane 1 Blotting, Western 1 Albumin-Bound Paclitaxel 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡